Brain and Cerebrospinal Fluid α‐Synuclein Real‐Time Quaking‐Induced Conversion Identifies Lewy Body Pathology in <scp>LRRK2‐PD</scp>-Reference-Cited by-同舟云学术

Brain and Cerebrospinal Fluid α‐Synuclein Real‐Time Quaking‐Induced Conversion Identifies Lewy Body Pathology in LRRK2‐PD

Published:2022-12-05 Issue:2 Volume:38 Page:333-338
ISSN:0885-3185
Container-title:Movement Disorders
language:en
Short-container-title:Movement Disorders

Author:

Garrido Alicia¹²³^ORCID,Fairfoul Graham⁴^ORCID,Tolosa Eduardo²³^ORCID,Marti Maria J.¹²³^ORCID,Ezquerra Mario²^ORCID,Green Alison J E⁴^ORCID

Affiliation:

1. Parkinson's Disease and Movement Disorders Unit, Institut Clínic de Neurociències Hospital Clinic de Barcelona Barcelona Spain

2. Laboratory of Parkinson Disease and Other Neurodegenerative Movement Disorders: Clinical and Experimental Research, Institut d'Investigacions Biomèdiques August Pi i Sunyer University of Barcelona Barcelona Spain

3. Centre for Networked Biomedical Research on Neurodegenerative Diseases (CIBERNED) Barcelona Spain

4. The National CJD Research & Surveillance Unit, Centre for Clinical Brain Sciences University of Edinburgh Edinburgh United Kingdom

Funder

Michael J. Fox Foundation

Publisher

Wiley

Subject

Neurology (clinical),Neurology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/mds.29284

Reference37 articles.

1. Clinical features ofLRRK2-associated Parkinson's disease in central Norway

2. Familial Parkinson's disease: Clinical and genetic analysis of four Basque families

3. LRRK2 Mutations in Spanish Patients With Parkinson Disease

4. Phenotype, genotype, and worldwide genetic penetrance of LRRK2-associated Parkinson's disease: a case-control study

5. MarrasC SchueleB MunhozRP et al.Phenotype in parkinsonian and nonparkinsonian LRRK2 G2019S mutation carriers. Accessed August 21 2017.https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3140802/pdf/znl325.pdf

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. LRRK2-Associated Parkinsonism With and WithoutIn VivoEvidence of Alpha-Synuclein Aggregates;2024-07-22

2. α-Synuclein seed amplification technology for Parkinson’s disease and related synucleinopathies;Trends in Biotechnology;2024-07

3. Single molecule array measures of LRRK2 kinase activity in serum link Parkinson’s disease severity to peripheral inflammation;Molecular Neurodegeneration;2024-06-11

4. Parkinson's Disease Associated with G2019S LRRK2 Mutations without Lewy Body Pathology;Movement Disorders Clinical Practice;2024-05-16

5. Peripheral cutaneous synucleinopathy characteristics in genetic Parkinson’s disease;Frontiers in Neurology;2024-05-01